These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 7879260

  • 1. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ, Harmer AW, Koffman CG, Vaughan RW.
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract] [Full Text] [Related]

  • 2. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A, Siddiqui JA, Rai A, Margoob A, Khaira A, Bhowmik D, Tiwari SC, Guleria S, Mehra NK.
    Clin Transpl; 2007 Feb; ():211-7. PubMed ID: 18637472
    [Abstract] [Full Text] [Related]

  • 3. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 May; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N, Terasaki PI, Schönemann C.
    Clin Transpl; 2006 May; ():171-99. PubMed ID: 18365377
    [Abstract] [Full Text] [Related]

  • 7. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD.
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [Abstract] [Full Text] [Related]

  • 8. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections.
    Harmer AW, Koffman CG, Heads AJ, Vaughan RW.
    Transplant Proc; 1995 Feb; 27(1):666-7. PubMed ID: 7879137
    [No Abstract] [Full Text] [Related]

  • 9. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC, Zhu L, Terasaki PI, Everly MJ.
    Transplantation; 2009 Aug 27; 88(4):568-74. PubMed ID: 19696641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.
    Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494
    [Abstract] [Full Text] [Related]

  • 12. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
    Reed E, Cohen DJ, Barr ML, Ho E, Marboe CC, Rose EA, Hardy M, Suciu-Foca N.
    Transplant Proc; 1992 Dec 27; 24(6):2494-5. PubMed ID: 1465842
    [Abstract] [Full Text] [Related]

  • 13. Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival.
    Lee PC, Ozawa M, Hung CJ, Lin YJ, Chang SS, Chou TC.
    Transplant Proc; 2009 Dec 27; 41(1):121-3. PubMed ID: 19249493
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML, Smith JD.
    Hum Immunol; 2009 Aug 27; 70(8):605-9. PubMed ID: 19375471
    [Abstract] [Full Text] [Related]

  • 15. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML, Cohen DJ, Benvenisty AI, Hardy M, Reemtsma K, Rose EA, Marboe CC, D'Agati V, Suciu-Foca N, Reed E.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [Abstract] [Full Text] [Related]

  • 16. [Anti HLA post-transplant antibodies. A new method of monitorization].
    López-Hoyos M, Fernández-Fresnedo G, Pastor JM, Arias M.
    Nefrologia; 2004 Feb 27; 24 Suppl 4():62-6. PubMed ID: 15279389
    [No Abstract] [Full Text] [Related]

  • 17. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP, Dendievel J, Roels L, Waer M, Vanrenterghem Y, Vermylen C.
    Transplant Proc; 1992 Dec 27; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract] [Full Text] [Related]

  • 18. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L, Conca R, Magistroni P, Leonardi G, Oda A, Rosati F, Leone E, Tacconella M, Roggero S, Segoloni GP, Amoroso A.
    Transpl Immunol; 2008 Jul 27; 19(3-4):238-43. PubMed ID: 18675725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.